NeuroMetrix, a medical device company focused on neurologic complications of diabetes, has announced a distribution agreement with OneSource Medical Group for its pain management device SENSUS. The device is a transcutaneous electrical nerve stimulator intended for the symptomatic relief and management of chronic intractable pain in the lower leg and foot. The device has FDA clearance and the company is planning a full launch during the first quarter of next year.
More Articles on Pain Management:
Dr. Vladimir Redko Joins North American Spine
Washington Center for Pain Management to Expand
Ameridose Recalls Products After FDA Investigation
More Articles on Pain Management:
Dr. Vladimir Redko Joins North American Spine
Washington Center for Pain Management to Expand
Ameridose Recalls Products After FDA Investigation